Reduction in Pruritus Across Indications in Phase 3 Trials of Topical Roflumilast. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 4, p. s587, 2025. DOI: 10.25251/579nct27. Disponível em: https://skin.dermsquared.com/skin/article/view/3494. Acesso em: 2 oct. 2025.